Ralitoline reevaluation anticonvulsant profile determination active plasma concentrations comparison prototype antiepileptic drugs mice Ralitoline RLT new thiazolidinone derivative potent anticonvulsant activity different seizure models Phase studies RLT human volunteers linear pharmacokinetics dose range mg RLT clinical Phase II studies interested predictive data effective plasma concentrations patients purpose anticonvulsant potency RLT seizure models mice plasma levels time peak drug effect models threshold maximal tonic extension electroshock seizures MES threshold clonic seizures i.v infusion pentylenetetrazol PTZ traditional MES test supramaximal mA stimulation clonic seizures administration PTZ Furthermore median minimal neurotoxic doses rotorod chimney test calculation protective indices data RLT data standard antiepileptic drugs phenobarbital phenytoin valproate diazepam onset anticonvulsant action i.p injection RLT rapid peak drug effect min MES models RLT potent compound Active plasma levels ng/ml MES threshold test ng/ml MES test RLT capable PTZ threshold whereas short duration action mice active PTZ seizure test 